CARDIOME PHARMA CORP's ticker is CRME and the CUSIP is 14159U301. A total of 32 filers reported holding CARDIOME PHARMA CORP in Q2 2016. The put-call ratio across all filers is 8.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $11,000 | -47.6% | 4,919 | -63.8% | 0.00% | – |
Q4 2017 | $21,000 | +320.0% | 13,590 | +547.1% | 0.00% | – |
Q3 2017 | $5,000 | -90.7% | 2,100 | -82.7% | 0.00% | – |
Q2 2017 | $54,000 | -54.2% | 12,140 | -68.9% | 0.00% | – |
Q1 2017 | $118,000 | -35.2% | 39,000 | -40.4% | 0.00% | – |
Q4 2016 | $182,000 | +83.8% | 65,406 | +106.4% | 0.00% | – |
Q3 2016 | $99,000 | -23.3% | 31,696 | +25.5% | 0.00% | – |
Q2 2016 | $129,000 | +514.3% | 25,255 | +399.9% | 0.00% | – |
Q1 2016 | $21,000 | -85.4% | 5,052 | -71.7% | 0.00% | – |
Q4 2015 | $144,000 | -49.8% | 17,825 | -47.7% | 0.00% | – |
Q3 2015 | $287,000 | +19.6% | 34,057 | +33.8% | 0.00% | – |
Q2 2015 | $240,000 | +15.4% | 25,461 | +13.3% | 0.00% | – |
Q1 2015 | $208,000 | +56.4% | 22,465 | +56.1% | 0.00% | – |
Q4 2014 | $133,000 | -8.3% | 14,388 | -11.1% | 0.00% | – |
Q3 2014 | $145,000 | -57.0% | 16,188 | -62.2% | 0.00% | – |
Q2 2014 | $337,000 | +137.3% | 42,833 | +139.1% | 0.00% | – |
Q1 2014 | $142,000 | +19.3% | 17,916 | -6.5% | 0.00% | – |
Q4 2013 | $119,000 | – | 19,152 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alistair Capital Management, L.L.C. | 917,400 | $5,715,000 | 2.56% |
Fortress Investment Group LLC | 2,481,596 | $15,460,000 | 0.24% |
PERKINS CAPITAL MANAGEMENT INC | 14,000 | $87,000 | 0.06% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,332,260 | $8,386,000 | 0.02% |
TFS CAPITAL LLC | 26,116 | $163,000 | 0.01% |
GROUP ONE TRADING, L.P. | 54,815 | $342,000 | 0.01% |
Renaissance Technologies | 218,913 | $1,364,000 | 0.00% |
Alberta Investment Management Corp | 19,140 | $128,000 | 0.00% |
OAK RIDGE INVESTMENTS LLC | 11,055 | $69,000 | 0.00% |
CLEAR STREET MARKETS LLC | 600 | $4,000 | 0.00% |